NEW YORK, Aug 1 –Corvas International has signed a multi-year subscription to Incyte’s LifeSeq Gold database, the companies said Wednesday.

Corvas said it would use the database for its cancer research activities. The San Diego-based company is currently researching serine proteases to determine their potential as solid tumor drug targets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.